Features
Building to Stay Independent in the Modern Ophthalmology Landscape
Strategies for maintaining practice independence through succession planning, physician partnerships, new revenue opportunities, and sustainable growth without private equity.
By Veronica Daub
Essential MIGS Skills
Practical techniques to help ophthalmologists individualize glaucoma treatment and incorporate interventional approaches into everyday practice.
By Julie Greenbaum, editor
Transitioning to Dropless Cataract Surgery
Clinical evidence, practical considerations, and sustainability benefits of dropless cataract surgery as an alternative to traditional postoperative eye-drop regimens.
By Julie Greenbaum, editor
Making the Case for DALK
An look into the advantages of deep anterior lamellar keratoplasty and practical techniques to help cornea surgeons overcome barriers to adoption.
By
Putting AI Into Practice
Exploring real-world applications of AI to streamline operations, improve staff training, and increase efficiency while emphasizing the importance of human oversight.
By Veronica Daub
Preparing for the AI-Enabled Practice
How practices can approach AI adoption strategically, with careful consideration of vendor contracts, data use, intellectual property, and long-term commitments.
By Veronica Daub
Making Practice Metrics Matter
Alexandra Acabá Berrocal, DHA, FACMPE, MSW, discusses her recent AAO 2026 workshop, “Sustainable Growth for Small Practices: Designing Performance-Driven Incentive Plans”
By
Helping Surgeons Transition to CAIRS
Soosan Jacob, MS, FRCS, DNB, MNAMS, explains what was covered in her recent AAO 2026 instruction course, “Transitioning to CAIRS.”
By
Decoding Cataract Dissatisfaction
Clinicians can systematically identify the source of postoperative cataract dissatisfaction in patients.
By
Moving Beyond the Budget
Practical strategies for strengthening ophthalmology practice budgets and alleviating financial pressure.
By
Key Metrics for Ophthalmology Revenue Cycle Success
How practices can boost revenue cycle health using essential KPIs.
By Julie Greenbaum, editor
A Toolkit for Secondary IOLs
Secondary IOL placement techniques and key considerations for selecting the most appropriate approach for patients with dislocated lenses.
By
Bringing AI Into Cataract Care
Ophthalmologists share real-world experiences using AI to streamline cataract consultations, support postoperative monitoring, and enhance patient care while maintaining physician oversight.
By Veronica Daub
Oculis Outlines Genotype-Based Dry Eye Strategy
The phase 3 PREDICT-1 trial is evaluating licaminlimab in patients with dry eye disease, with a primary analysis focused on a genetically defined subgroup.
Departments
Designing Better First Impressions
Simple updates to reception areas, waiting rooms, and check-in processes can improve the patient experience without requiring a major renovation.
By Veronica Daub
News
Defusing the Confusion of the Jackson Cross Cylinder
Experts provide steps for using this ophthalmic lens to determine both cylinder axis and power.
By Julie Greenbaum, editor
The Critical Role of Medication Reviews in Ophthalmic Care
From retinal toxicity to cataract surgery complications, systemic medications can reveal important clinical risks that technicians can help identify.
By Julie Greenbaum, editor
Three-Year Data Show Vision Gains Maintained With Subretinal Implant
New data from a European trial suggest that vision restored by a chip placed beneath the retina can last.
Everyday Beauty Products Send Thousands to the ER With Eye Injuries Each Year
A study examined emergency room visits over a 20-year period and found that the risks shift with age.
Bimatoprost IOL Shows 12-Month IOP Reductions
Phase 1/2 findings presented at AAO 2026 show high rates of medication independence and comparable safety outcomes following cataract surgery.
Lumenis Launches Ocular Surface Care Guide
The resource offers current research, clinical insights, and practical strategies to incorporate ocular surface care into existing workflows.
Merck Reports Positive Phase 2b/3 DME Results for Remigromig
Remigromig demonstrated noninferiority in mean change from baseline in BCVA vs ranibizumab at 1 year in patients with diabetic macular edema.
Elegrobart Meets Phase 3 Primary Endpoint in TED
Viridian Therapeutics presented the top-line data at the 2026 AAO meeting.